PE
NEO icon

Point72 Europe’s NeoGenomics NEO Stock Holding History

Point72 Europe’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12.5K Buy
+1,620
New +$11.3K ﹤0.01% 514

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Europe's NEO Position: Q3 2025 in Review

Point72 Europe opened a new position in NeoGenomics (NEO) in Q3 2025: 1,620 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #514 among its holdings.

254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Point72 Europe held 1,620 shares of NeoGenomics worth $12.5K as of Q3 2025.
  • NeoGenomics was a new Point72 Europe position in Q3 2025.
  • NeoGenomics made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #514 holding.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.